Pasar al contenido principal

MEMORIA INFLAMATORIA EPIGENETICA DE LAS OPCS EN ESCLEROSIS MULTIPLE: UN ARMA DE DOBLE FILO EN EL ENVEJECIMIENTO Y LA REMIELINIZACION

PID2024-161979OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Neurovascular Niche: A Gathering Venue for Neuroinflammation and Remyelination in Multiple Sclerosis

  • Kazanis, Ilias
  • Silva, Maria Elena
  • Fuente, Alerie G. de la
  • Castro Soubriet, Fernando de
  • Rivera, Francisco J.
In the central nervous system (CNS), the tissue microenvironment is continuously monitored and regulated to secure the unobstructed function of neurons and of their networks. This is a key function of the neurovascular niche (NVN), which is the interface between the cells of the nervous tissue and the cells and the content of blood vessels. It is enabled by the Blood-Brain Barrier, a structure formed by endothelial and perivascular cells, extracellular matrix, and astrocytes, and is manifested by the limited surveillance of the CNS from blood-derived cells. Multiple sclerosis (MS) is a devastating degenerative disorder, in which the myelin sheaths that enwrap neuronal axons are destroyed, leading, over time, to neurological symptoms. MS has a strong immunological component which is targeted in most of the current disease-modifying treatments. Nevertheless, regenerative interventions aiming at enhancing and restoring the endogenous remyelination potential of the CNS, driven by the abundant Oligodendrocyte Progenitor Cells (OPCs), have not been successfully developed so far. Here, we will review key information on the structure of the NVN, and we will summarize the evidence on the role of inflammation in the emergence and the progress of MS, with a focus on the active response of OPCs. We will also present recent experimental evidence on the role of less investigated cellular elements of the NVN, such as pericytes and platelets, in the regulation of OPCs. Finally, we will discuss current and future treatments for MS., This work was supported by the Research Council of Finland (Suomen Akatemia) - Academy Project 370013 to Francisco J. Rivera; the Sigrid Jusélius Foundation (Sigrid Juséliuksen Säätiö) to Francisco J. Rivera; the Finnish Multiple Sclerosis Foundation (Suomen MS-Säätiö) to Francisco J. Rivera; and the Chilean National Agency for Research and Development (Agencia Nacional de Investigación y Desarrollo, ANID) - FONDECYT Regular 1201706 to Francisco J. Rivera. In addition to this, this work was supported by the Spanish Ministerio de Ciencia e Investigación-MCIN and the Agencia Estatal de Investigación-AEI (grant PID2022-143110OB-I00 funded by MCIN/AEI/10.13039/501100011033/and by “ERDF A way of making Europe”, by the European Union to Fernando de Castro and PID2024-161979OB-I00 funded by MICIU/AEI/13.13039/501100011033 and EDRF/EU to Alerie G. de la Fuente), a contract #050601240019 “LeukoReMy” (financed by Asociación Europea contra la Leucodistrofia-ELA -Spain- and Fundación Hesperia -Spain-) to Fernando de Castro and a Ramón y Cajal Fellowship from the Ministerio de Ciencia Inovación y Universidades, Agencia Estatal de Investigación (RYC2023-045776-I, funded by MICIU/AEI/13.13039/501100011033 and FSE+) to Alerie G. de la Fuente. Also, by a research grant from the Hellenic Foundation for Research and Innovation (HFRI-FM17-3395) to Ilias Kazanis., Open access publishing facilitated by Helsingin yliopisto, as part of the Wiley - FinELib agreement., Peer reviewed